Zapping pain away: electrical acupoint therapy tested after lung surgery
NCT ID NCT07287657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding transcutaneous electrical acupoint stimulation (TEAS) to standard pain relief can reduce pain and inflammation after lung cancer surgery. 90 people scheduled for thoracic surgery will receive either standard care alone or standard care plus TEAS. The goal is to see if this non-invasive approach improves recovery and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcutaneous Electrical Acupoint Stimulation (TEAS) and Transcutaneous Electrical Nerve Stimulation (TENS)
- What this could lead to
- If it works, this could offer a drug-free way to ease pain after lung surgery and reduce reliance on painkillers.
- What could go wrong
- This is a small, early-stage study with no blinding, so results may be influenced by placebo effects. The approach may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
15 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * People who are about to undergo thoracic surgery Exclusion Criteria: * Patients with epilepsy, * Pacemaker installed * Severe infections status
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hualien Tzu Chi Hospital
Taipei, Hualien, 97002, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Fibrotic drug shield lungs from radiation after immunotherapy?
- App aims to catch a hidden radiotherapy side effect
- Three ways to block hernia surgery pain go head to head
- Which nerve block wins for lung surgery pain?
- Could a small electrical device cut painkiller use after hip surgery?
- Can a blood pressure drug cut opioid needs during bowel surgery?